2012-09-18 08:03:14 - New Pharmaceuticals market report from Global Markets Direct: "AndroScience Corporation - Product Pipeline Review - 2012"

Global Markets Direct's pharmaceuticals report, "AndroScience Corporation - Product Pipeline Review - 2012" provides data on the AndroScience Corporation's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, AndroScience Corporation's corporate website, SEC filings, investor presentations and featured press releases, both from AndroScience Corporation and industry-specific third party sources, put together by Global Markets Direct's team.

Scope

* AndroScience Corporation - Brief AndroScience Corporation overview including business description, key information and facts, and its locations and subsidiaries.
* Review of current pipeline of AndroScience Corporation

human therapeutic division.
* Overview of pipeline therapeutics across various therapy areas.
* Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
* Product profiles for late stage and clinical stage products of AndroScience Corporation with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
* Recent updates of the AndroScience Corporation's pipeline in the last quarter.
* Key discontinued and dormant projects.
* Latest news and deals relating to the products.


Full Report Details at
- www.fastmr.com/prod/463662_androscience_corporation_product_pipe ..


Reasons to buy

* Evaluate AndroScience Corporation's strategic position with total access to detailed information on its product pipeline.
* Assess the growth potential of AndroScience Corporation in its therapy areas of focus.
* Identify new drug targets and therapeutic classes in the AndroScience Corporation's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
* Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
* Exploit collaboration and partnership opportunities with AndroScience Corporation.
* Avoid Intellectual Property Rights related issues.
* Explore the dormant and discontinued projects of AndroScience Corporation and identify potential opportunities in those areas.

Keywords

Current R&D Portfolio of AndroScience Corporation; AndroScience Corporation - Key Therapeutics; AndroScience Corporation - Pipeline Overview and Promising Molecules; AndroScience Corporation - News; AndroScience Corporation - Latest Updates; AndroScience Corporation - Pipeline; AndroScience Corporation - Discontinued/Dormant Projects

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
AndroScience Corporation Snapshot
AndroScience Corporation Overview
Key Information
Key Facts
AndroScience Corporation - Research and Development Overview
Key Therapeutic Areas
AndroScience Corporation - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
AndroScience Corporation - Pipeline Products Glance
AndroScience Corporation Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
AndroScience Corporation - Early Stage Pipeline Products
Pre-Clinical Products/Combination Treatment Modalities
AndroScience Corporation - Drug Profiles
ASC-J9
Product Description
Mechanism of Action
R&D Progress
ASC-JM.X2
Product Description
Mechanism of Action
R&D Progress
ASC-JM.Z1
Product Description
Mechanism of Action
R&D Progress
ASC-ST.X1
Product Description
Mechanism of Action
R&D Progress
ASC-ST.Z1
Product Description
Mechanism of Action
R&D Progress
AndroScience Corporation - Pipeline Products by Route of Administration
AndroScience Corporation - Pipeline Products By Mechanism of Action
AndroScience Corporation - Locations And Subsidiaries
Head Office
Financial Deals Landscape
AndroScience Corporation, Deals Summary
AndroScience Corporation, Pharmaceuticals & Healthcare, Deal Details
Venture Financing
AndroScience Secures $6.4 Million In Venture Financing
Partnerships
AndroScience Enters Into Collaboration With Orient Europharma
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
AndroScience Corporation, Key Information
AndroScience Corporation, Key Facts
AndroScience Corporation - Pipeline by Indication, 2012
AndroScience Corporation - Pipeline by Stage of Development, 2012
AndroScience Corporation - Monotherapy Products in Pipeline, 2012
AndroScience Corporation - Phase II, 2012
AndroScience Corporation - Pre-Clinical, 2012
AndroScience Corporation - Pipeline By Route of Administration, 2012
AndroScience Corporation - Pipeline Products By Mechanism of Action, 2012
AndroScience Corporation, Deals Summary

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=463662&dt=t

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.